유틸렉스

263050KOSDAQ기초 의약물질 제조업

32.0 / 100

Reference Date: 2026-04-13

Financial Score15.5 / 40

News Sentiment2.5 / 25

Momentum10.0 / 20

Disclosure4.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Roughly flat over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

Utillex is a biotech company established in 2015, focusing on R&D of immunotherapies such as CAR-T and antibody-based treatments. Its key pipeline, EU307, is a 4th-generation armored CAR-T therapy targeting GPC3 in solid tumors, while EU103 converts M2 macrophages to M1 to enhance immune responses, both currently in Phase I clinical trials. The company also operates IT services and research-related business.

Number of Employees

119people

Average Salary

55.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.454.0Point

PBR

2.24Industry Average 2.032.5Point

Higher than industry avg (caution)

ROE

-88.55Industry Average -4.293.5Point

20.6x industry avg (excellent)

Debt Ratio

21.94Industry Average 6.610.0Point

3.3x industry avg (risky)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲3572.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲19.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -60.4% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 0Neutral 0Negative 4Average Sentiment Score 10

Negative
유틸렉스, 회생절차 개시…권병세 대표, 관리인 역할 수행
유틸렉스는 서울회생법원이 회생절차 개시를 결정했으며, 권병세 대표가 관리인 역할을 수행하게 됩니다.
Negative
유틸렉스, 감사의견 거절…상장폐지 사유 발생
유틸렉스는 지난해 재무제표에 대한 감사의견이 '의견거절'로 상장폐지 사유가 발생했으며, 유동부채 초과 및 회생 절차 신청으로 계속기업 불확실성이 커졌습니다.
Negative
유틸렉스, 상장적격성 실질심사 대상 결정
유틸렉스는 상장적격성 실질심사 대상에 해당되어 상장폐지 가능성이 검토될 예정입니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 959Won52-week high 2,74052-week low 683

1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

15 totalPositive 0Neutral 13Negative 2

Neutral기타주요경영사항 (임시주주총회 소집 철회)2026-04-07
Neutral[기재정정]주주총회소집결의 (철회)2026-04-07
Neutral정기주주총회결과2026-03-31
Negative주권매매거래정지기간변경 (회생절차 개시결정)2026-03-30
Negative회생절차개시결정2026-03-30